Pregled bibliografske jedinice broj: 1229511
Rapid capillary electrophoresis method for simultaneous determination of abemaciclib, ribociclib, and palbociclib in pharmaceutical dosage forms: a green approach
Rapid capillary electrophoresis method for simultaneous determination of abemaciclib, ribociclib, and palbociclib in pharmaceutical dosage forms: a green approach // Molecules, 27 (2022), 21; 7603, 13 doi:10.3390/molecules27217603 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1229511 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Rapid capillary electrophoresis method for
simultaneous determination of abemaciclib,
ribociclib, and palbociclib in pharmaceutical
dosage forms: a green approach
Autori
Mlinarić, Zvonimir ; Turković, Lu ; Begović, Iva ; Nigović, Biljana ; Sertić, Miranda
Izvornik
Molecules (1420-3049) 27
(2022), 21;
7603, 13
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
CDK4/6 inhibitors ; abemaciclib ; ribociclib ; palbociclib ; breast cancer ; green chemistry ; capillary electrophoresis
Sažetak
Advances in the treatment of HR+/HER2- breast cancer phenotype have been made with the introduction of abemaciclib, ribociclib, and palbociclib, inhibitors of cyclin D dependent kinases 4 and 6 (CDK4/6). Here, a novel, fast, cheap, and green CE method for the simultaneous determination of these three CDK4/6 inhibitors in less than 4 min is proposed for the first time. Separation was achieved by capillary zone electrophoresis in an acidic medium, in accordance with the structures of the analytes and their pKa values. The optimal pH of the running buffer was found to be 2.9. The optimal method conditions were 27.5 kV separation voltage, 30 °C, 5 s injection time under 50 mbar pressure, and 50 mM phosphate background buffer with benzimidazole as an internal standard. The developed method was validated with respect to robustness, selectivity, accuracy, precision, linearity, and limits of detection. The method was shown to be linear in the range of 10 to 100 µg mL−1 with correlation coefficients higher than 0.9981. A greenness assessment of the proposed method was performed, and the method was shown to be green. The validated method was successfully applied to pharmaceutical dosage forms of all CDK4/6 inhibitors.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Projekti:
UIP-2019-04-8461 - Nova bioanalitička rješenja za personalizaciju terapije raka dojke (OncoBioAnalytics) (Sertić, Miranda, HRZZ - 2019-04) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Profili:
Lu Turković
(autor)
Biljana Nigović
(autor)
Miranda Sertić
(autor)
Zvonimir Mlinarić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE